Cargando…
Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
Development of multidrug resistance (MDR) is a major deterrent in the effective treatment of metastatic cancers by chemotherapy. Even though MDR and cancer invasiveness have been correlated, the molecular basis of this link remains obscure. We show here that treatment with chemotherapeutic drugs inc...
Autores principales: | Saxena, M, Stephens, M A, Pathak, H, Rangarajan, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199722/ https://www.ncbi.nlm.nih.gov/pubmed/21734725 http://dx.doi.org/10.1038/cddis.2011.61 |
Ejemplares similares
-
Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
por: Jiang, Zong-Sheng, et al.
Publicado: (2017) -
AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation
por: Saxena, Meera, et al.
Publicado: (2018) -
Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression
por: Pang, Jianan, et al.
Publicado: (2017) -
Schistosome ABC multidrug transporters: From pharmacology to physiology
por: Greenberg, Robert M.
Publicado: (2014) -
A Multidrug ABC Transporter with a Taste for Salt
por: Velamakanni, Saroj, et al.
Publicado: (2009)